U.S. markets closed

AIkido Pharma Inc. (AIKI)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
0.9123+0.0305 (+3.46%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Momentum

Momentum

Previous Close0.8818
Open0.8800
Bid0.8910 x 1000
Ask0.9100 x 1000
Day's Range0.8703 - 0.9319
52 Week Range0.4700 - 2.5500
Volume917,697
Avg. Volume11,928,727
Market Cap81.109M
Beta (5Y Monthly)1.57
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateMay 12, 1980
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Newsfile

    AIkido Pharma Inc. Announces Participation in the Benzinga Global Small Cap Conference

    Detroit, Michigan--(Newsfile Corp. - May 6, 2021) - AIkido Pharma Inc. (NASDAQ:AIKI) will be presenting at the Benzinga Global Small Cap Conference taking place on May 13-14, 2021. We invite our shareholders and all interested parties to explore investment opportunities within the global small cap space.Sign up to get a free spectator pass for the event: https://www.benzinga.com/events/small-cap/global/About the Benzinga Global Small Cap ConferenceThe Benzinga Global Small Cap Conference bridges the gap between Small Cap ...

  • AIkido Pharma Announces Dr. Rachel Yehuda's Appearance at SXSW
    PR Newswire

    AIkido Pharma Announces Dr. Rachel Yehuda's Appearance at SXSW

    AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that Dr. Rachel Yehuda appeared at SXSW for a panel discussion entitled Psychedelics: Rewiring Mental Health Care. The Company is a proud supporter of Dr. Yehuda's research. The SXSW panel discussed ongoing clinical trials, recent medical discoveries, and how psilocybin may be part of the solution to our mental health crisis. The session is available on demand at the SXSW website.

  • AIkido Pharma Announces Inventor and Scientist Dr. Matthew Frieman Joins Scientific Advisory Board
    PR Newswire

    AIkido Pharma Announces Inventor and Scientist Dr. Matthew Frieman Joins Scientific Advisory Board

    AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that Dr. Matthew Frieman has joined the Company's Scientific Advisory Board.